About the journal
Cancer immunity is a journal published by Springer Science+Business Media in Switzerland. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1424-9634
- Country
- Switzerland
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://www.cancerimmunity.org/index.htm
Index listings
- PUBMED · 2001-03-30
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2010
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
94
Last recorded publication year
2013
h-index
4
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy(no data)
No data available to the platform for this group
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101119871
Classification(no data)
No data available to the platform for this group
No platform data for: Editorial & policy · Classification — absence is not a judgment about the journal.
Subject areas
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
Show all subjects (50)
- CAR-T cell therapy research
- CAR-T cell therapy research
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Virus-based gene therapy research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Virus-based gene therapy research
- HIV Research and Treatment
- HIV Research and Treatment
- Immune cells in cancer
- Immune cells in cancer
- Peptidase Inhibition and Analysis
- RNA Interference and Gene Delivery
- Peptidase Inhibition and Analysis
- RNA Interference and Gene Delivery
- Cervical Cancer and HPV Research
- SARS-CoV-2 and COVID-19 Research
- Glycosylation and Glycoproteins Research
- Cytomegalovirus and herpesvirus research
- Phagocytosis and Immune Regulation
- Poxvirus research and outbreaks
- Cervical Cancer and HPV Research
- SARS-CoV-2 and COVID-19 Research
- Phagocytosis and Immune Regulation
- Glycosylation and Glycoproteins Research
- Poxvirus research and outbreaks
- Cytomegalovirus and herpesvirus research
- Prostate Cancer Treatment and Research
- HIV/AIDS drug development and treatment
- Hepatitis B Virus Studies
- Influenza Virus Research Studies
- Hematopoietic Stem Cell Transplantation
- Hepatitis B Virus Studies
- Influenza Virus Research Studies
- Epigenetics and DNA Methylation
- HIV/AIDS drug development and treatment
- Immune Response and Inflammation
- Immune Response and Inflammation
- Hematopoietic Stem Cell Transplantation
- Prostate Cancer Treatment and Research
- Epigenetics and DNA Methylation
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ